• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 5, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Universal gut microbiome-derived signature predicts cirrhosis

Bioengineer by Bioengineer
June 30, 2020
in Health
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Used as a noninvasive diagnostic tool, it might help patients with common nonalcoholic fatty liver disease avoid one of its deadly, progressive complications

IMAGE

Credit: National Institute of Diabetes and Digestive and Kidney Diseases

Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease worldwide, affecting an estimated one-quarter of the global population. It is a progressive condition that, in worst cases, can lead to cirrhosis, liver cancer, liver failure and death.

In a new paper published online June 30, 2020 in Cell Metabolism, a team of scientists, led by researchers at University of California San Diego School of Medicine, report that stool microbiomes — the collection of microorganisms found in fecal matter and in the gastrointestinal tract — of NAFLD patients are distinct enough to potentially be used to accurately predict which persons with NAFLD are at greatest risk for having cirrhosis — the late-stage, irreversible scarring of the liver that often requires eventual organ transplantation.

“The findings represent the possibility of creating an accurate, stool microbiome-based, non-invasive test to identify patients at greatest risk for cirrhosis,” said senior author Rohit Loomba, MD, professor of medicine in the Division of Gastroenterology at UC San Diego School of Medicine and director of its NAFLD Research Center. “Such a diagnostic tool is urgently needed.”

Loomba said a novel aspect of the study is the external validation of gut microbiome signatures of cirrhosis in participant cohorts from China and Italy. “This is one of the first studies to show such a robust external validation of a gut microbiome-based signature across ethnicities and geographically distinct cohorts.

The work builds upon previous published research in 2017 and 2019 by Loomba and colleagues.

A link between NAFLD and the gut microbiome is well-documented, but specifics were scant and it has not been clear that discrete metagenomics and metabolomics signatures might be used to detect and predict cirrhosis. In the latest study, researchers compared the stool microbiomes of 163 participants encompassing patients with NAFLD-cirrhosis, their first-degree relatives and control-patients without NAFLD.

Combining metagenomics signatures with participants’ ages and serum albumin (an abundant blood protein produced in the liver) levels, the scientists were able to accurately distinguish cirrhosis in participants differing by cause of disease and geography.

The next step, said Loomba, is to establish causality of these gut microbial species or their metabolites in causing cirrhosis, and whether this test can be used and scaled up for clinical use.

###

Co-authors include: Tae Gyu Oh, Ting Fu, Ruth T. Yu, Annette R. Atkins and Michael Downes, Salk Institute for Biological Studies; Susy M. Kim, Shirin Bassirian, Seema Singh, Egbert V. Madamba, Lisa Richards, Ricki Bettencourt, Pieter Dorrestein, David A. Brenner, Claude B. Sirlin, and Rob Knight, UC San Diego; Cyrielle Caussy, UC San Diego and University of Lyon, France; Jian Guo and Tao Huan, University of British Columbia, Vancouver; Manuela Raffatellu, UC San Diego and Chiba University-UC San Diego Center for Mucosal Immunity, Allergy and Vaccines; and Ronald M. Evans, Salk Institute for Biological Sciences, and Howard Hughes Medical Institute.

Media Contact
Scott LaFee
[email protected]

Related Journal Article

http://dx.doi.org/10.1016/j.cmet.2020.06.005

Tags: Clinical TrialsInternal MedicineLiverMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

Supporting Caregivers of COPD Patients: Key Insights

October 5, 2025

Evaluating Mid-Upper Arm Circumference for Child Thinness

October 5, 2025

GDI-PMNet Enables Joint Prediction of Glioma Markers

October 5, 2025

Racial Disparities in Anticoagulant Use for Atrial Fibrillation

October 5, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    94 shares
    Share 38 Tweet 24
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    92 shares
    Share 37 Tweet 23
  • Physicists Develop Visible Time Crystal for the First Time

    75 shares
    Share 30 Tweet 19
  • New Insights Suggest ALS May Be an Autoimmune Disease

    70 shares
    Share 28 Tweet 18

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Supporting Caregivers of COPD Patients: Key Insights

Exploring Plastid Genome Traits in Saururaceae

Evaluating Mid-Upper Arm Circumference for Child Thinness

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 62 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.